Quantification of in vivo binding of [3H]RX 821002 in rat brain: Evaluation as a radioligand for central α2-adrenoceptors
- 30 November 1992
- journal article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Vol. 19 (8) , 841-849
- https://doi.org/10.1016/0883-2897(92)90170-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efaroxan (RX 821037) is a potent and selective α2-adrenoceptor antagonist in human frontal cortex membranesNeurochemistry International, 1991
- High affinity binding of 3H rauwolscine and 3H RX781094 to α2 adrenergic receptors and non-stereo selective sites in human and rabbit brain cortex membranesBiochemical Pharmacology, 1989
- Chronic treatment with cholinesterase inhibitors increases α2-adrenoceptors in rat brainEuropean Journal of Pharmacology, 1988
- Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medicationJournal of Psychopharmacology, 1988
- Adrenergic receptor and catecholamine distribution in rat cerebral cortex: binding studies with [3H]prazosin, [3H]idazoxan and [3H]dihydroalprenololBrain Research, 1987
- Heterogeneity of mammalian α2-adrenoceptors delineated by [3H]yohimbine bindingEuropean Journal of Pharmacology, 1986
- Regional Brain Blood Flow, Blood Volume, and Haematocrit Values in the Adult RatJournal of Cerebral Blood Flow & Metabolism, 1983
- [3H]rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptorsEuropean Journal of Pharmacology, 1982
- Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist statesLife Sciences, 1976
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966